Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy
Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy is a paper indexed in PICO Portal from OpenAlex.
How many citations does Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy have?
Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy has 15 citations in the OpenAlex counts PICO Portal stores.
When was Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy published?
Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy has 2013 year in the PICO Portal index.
What is the open-access status of Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy?
Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy has bronze oa status in the PICO Portal index.
What is the DOI of Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy?
The DOI for Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy is on the source record.
What is the PMID of Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy?
The PMID for Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy is on the source record.
What is the OpenAlex record for Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy?
The OpenAlex for Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy is on the source record.